Vaxcyte (PCVX)
(Delayed Data from NSDQ)
$116.54 USD
-0.21 (-0.18%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $116.42 -0.12 (-0.10%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $-0.98 | 1.71% |
Earnings Summary
For their last quarter, Vaxcyte (PCVX) reported earnings of -$1.10 per share, beating the Zacks Consensus Estimate of $-1.14 per share. This reflects a positive earnings surprise of 3.51%. Look out for PCVX's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of -$0.98 per share, reflecting a year-over-year decrease of 7.69%.
Earnings History
Price & Consensus
Zacks News for PCVX
Vaxcyte Stock Hits Record High on Pneumococcal Vaccine Study Results
PCVX: What are Zacks experts saying now?
Zacks Private Portfolio Services